Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | AZD5335 |
Trade Name | |
Synonyms | AZD 5335|AZD-5335 |
Drug Descriptions |
AZD5335 is an antibody-drug conjugate (ADC) comprising an antibody targeting FOLR1 (FRalpha) linked to a topoisomerase 1 inhibitor, which potentially inhibits tumor growth (Cancer Res (2023) 83 (8_Supplement): LB025). |
DrugClasses | FOLR1-targeted Therapy 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
AZD5335 | AZD5335 | 0 | 1 |
AZD5335 + Saruparib | AZD5335 Saruparib | 0 | 1 |